On Wednesday, September 7, 2016, the Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) met by teleconference in open session from 1 p.m. to 2:20 p.m. US EDT to hear updates of research programs in the Gene Transfer and Immunogenicity Branch of the Division of Cellular and Gene Therapies in CBER’s Office of Cellular, Tissue, and Gene Therapies. After the updates, the meeting was closed to the public in order to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b(c)(6)). In closed sessions, the Committee discusses reports of intramural research programs and makes recommendations regarding personnel staffing decisions.